Endovascular and hybrid revascularization for complicated aorto-iliac occlusive disease: Short-term results in single institute experience

Tai Wei Chen, Chun Yang Huang, Po Lin Chen, Chiu Yang Lee, Chun Che Shih, I. Ming Chen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Treatment for extensive aortoiliac occlusive disease (AIOD) includes endovascular interventions, hybrid procedures and surgical reconstruction. This study evaluated the short-term outcomes of endovascular and hybrid procedures in patients with Trans-Atlantic Inter-Society Consensus II (TASC-II) D AIOD lesions. Materials and Methods: From January 2013 to June 2015, 41 patients with TASC-II D AIOD lesions who underwent revascularization at our institute were retrospectively included. Nineteen underwent endovascular procedures and 22 underwent hybrid procedures with a postoperative surveillance program for at least 1 year. Patient demographics and short-term outcomes were analyzed. Results: The procedural success rate in all patients was 100%. The accumulative postoperative complication rate was 20.2%, and the major complication was acute kidney injury (14.6%). The time of freedom from target lesion revascularization was 18.9 months. The primary patency rates in the endovascular group were 89.5% and 84.2% at 1 and 2 years, respectively, compared to 95.5% at 1 and 2 years in the hybrid group; however, the difference was not significant (p = 0.234). The secondary patency rates were 94.7% and 93% at 1 and 2 years, respectively, in the endovascular group, and 95.5% and 94% at 1 and 2 years, respectively, in the hybrid group; however, the differences was not significant (p = 0.916). Conclusions: Our study revealed that endovascular and hybrid procedures are favorable treatment choices for patients with TASC-II D AIOD lesions. In patients with multilevel steno-occlusive lesions, hybrid procedures improved distal runoff flow and reduced the complexity of endovascular procedures.

Original languageEnglish
Pages (from-to)313-320
Number of pages8
JournalActa Cardiologica Sinica
Volume34
Issue number4
DOIs
Publication statusPublished - Jul 1 2018
Externally publishedYes

Fingerprint

Endovascular Procedures
Acute Kidney Injury
Demography
Therapeutics

Keywords

  • Aorto-iliac occlusive disease
  • Hybrid operation
  • TASC-II D lesion

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Endovascular and hybrid revascularization for complicated aorto-iliac occlusive disease : Short-term results in single institute experience. / Chen, Tai Wei; Huang, Chun Yang; Chen, Po Lin; Lee, Chiu Yang; Shih, Chun Che; Chen, I. Ming.

In: Acta Cardiologica Sinica, Vol. 34, No. 4, 01.07.2018, p. 313-320.

Research output: Contribution to journalArticle

Chen, Tai Wei ; Huang, Chun Yang ; Chen, Po Lin ; Lee, Chiu Yang ; Shih, Chun Che ; Chen, I. Ming. / Endovascular and hybrid revascularization for complicated aorto-iliac occlusive disease : Short-term results in single institute experience. In: Acta Cardiologica Sinica. 2018 ; Vol. 34, No. 4. pp. 313-320.
@article{31cee2c720684a608a3007815a214ba9,
title = "Endovascular and hybrid revascularization for complicated aorto-iliac occlusive disease: Short-term results in single institute experience",
abstract = "Background: Treatment for extensive aortoiliac occlusive disease (AIOD) includes endovascular interventions, hybrid procedures and surgical reconstruction. This study evaluated the short-term outcomes of endovascular and hybrid procedures in patients with Trans-Atlantic Inter-Society Consensus II (TASC-II) D AIOD lesions. Materials and Methods: From January 2013 to June 2015, 41 patients with TASC-II D AIOD lesions who underwent revascularization at our institute were retrospectively included. Nineteen underwent endovascular procedures and 22 underwent hybrid procedures with a postoperative surveillance program for at least 1 year. Patient demographics and short-term outcomes were analyzed. Results: The procedural success rate in all patients was 100{\%}. The accumulative postoperative complication rate was 20.2{\%}, and the major complication was acute kidney injury (14.6{\%}). The time of freedom from target lesion revascularization was 18.9 months. The primary patency rates in the endovascular group were 89.5{\%} and 84.2{\%} at 1 and 2 years, respectively, compared to 95.5{\%} at 1 and 2 years in the hybrid group; however, the difference was not significant (p = 0.234). The secondary patency rates were 94.7{\%} and 93{\%} at 1 and 2 years, respectively, in the endovascular group, and 95.5{\%} and 94{\%} at 1 and 2 years, respectively, in the hybrid group; however, the differences was not significant (p = 0.916). Conclusions: Our study revealed that endovascular and hybrid procedures are favorable treatment choices for patients with TASC-II D AIOD lesions. In patients with multilevel steno-occlusive lesions, hybrid procedures improved distal runoff flow and reduced the complexity of endovascular procedures.",
keywords = "Aorto-iliac occlusive disease, Hybrid operation, TASC-II D lesion",
author = "Chen, {Tai Wei} and Huang, {Chun Yang} and Chen, {Po Lin} and Lee, {Chiu Yang} and Shih, {Chun Che} and Chen, {I. Ming}",
year = "2018",
month = "7",
day = "1",
doi = "10.6515/ACS.201807_34(4).20180301A",
language = "English",
volume = "34",
pages = "313--320",
journal = "Acta Cardiologica Sinica",
issn = "1011-6842",
publisher = "Republic of China Society of Cardiology",
number = "4",

}

TY - JOUR

T1 - Endovascular and hybrid revascularization for complicated aorto-iliac occlusive disease

T2 - Short-term results in single institute experience

AU - Chen, Tai Wei

AU - Huang, Chun Yang

AU - Chen, Po Lin

AU - Lee, Chiu Yang

AU - Shih, Chun Che

AU - Chen, I. Ming

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Background: Treatment for extensive aortoiliac occlusive disease (AIOD) includes endovascular interventions, hybrid procedures and surgical reconstruction. This study evaluated the short-term outcomes of endovascular and hybrid procedures in patients with Trans-Atlantic Inter-Society Consensus II (TASC-II) D AIOD lesions. Materials and Methods: From January 2013 to June 2015, 41 patients with TASC-II D AIOD lesions who underwent revascularization at our institute were retrospectively included. Nineteen underwent endovascular procedures and 22 underwent hybrid procedures with a postoperative surveillance program for at least 1 year. Patient demographics and short-term outcomes were analyzed. Results: The procedural success rate in all patients was 100%. The accumulative postoperative complication rate was 20.2%, and the major complication was acute kidney injury (14.6%). The time of freedom from target lesion revascularization was 18.9 months. The primary patency rates in the endovascular group were 89.5% and 84.2% at 1 and 2 years, respectively, compared to 95.5% at 1 and 2 years in the hybrid group; however, the difference was not significant (p = 0.234). The secondary patency rates were 94.7% and 93% at 1 and 2 years, respectively, in the endovascular group, and 95.5% and 94% at 1 and 2 years, respectively, in the hybrid group; however, the differences was not significant (p = 0.916). Conclusions: Our study revealed that endovascular and hybrid procedures are favorable treatment choices for patients with TASC-II D AIOD lesions. In patients with multilevel steno-occlusive lesions, hybrid procedures improved distal runoff flow and reduced the complexity of endovascular procedures.

AB - Background: Treatment for extensive aortoiliac occlusive disease (AIOD) includes endovascular interventions, hybrid procedures and surgical reconstruction. This study evaluated the short-term outcomes of endovascular and hybrid procedures in patients with Trans-Atlantic Inter-Society Consensus II (TASC-II) D AIOD lesions. Materials and Methods: From January 2013 to June 2015, 41 patients with TASC-II D AIOD lesions who underwent revascularization at our institute were retrospectively included. Nineteen underwent endovascular procedures and 22 underwent hybrid procedures with a postoperative surveillance program for at least 1 year. Patient demographics and short-term outcomes were analyzed. Results: The procedural success rate in all patients was 100%. The accumulative postoperative complication rate was 20.2%, and the major complication was acute kidney injury (14.6%). The time of freedom from target lesion revascularization was 18.9 months. The primary patency rates in the endovascular group were 89.5% and 84.2% at 1 and 2 years, respectively, compared to 95.5% at 1 and 2 years in the hybrid group; however, the difference was not significant (p = 0.234). The secondary patency rates were 94.7% and 93% at 1 and 2 years, respectively, in the endovascular group, and 95.5% and 94% at 1 and 2 years, respectively, in the hybrid group; however, the differences was not significant (p = 0.916). Conclusions: Our study revealed that endovascular and hybrid procedures are favorable treatment choices for patients with TASC-II D AIOD lesions. In patients with multilevel steno-occlusive lesions, hybrid procedures improved distal runoff flow and reduced the complexity of endovascular procedures.

KW - Aorto-iliac occlusive disease

KW - Hybrid operation

KW - TASC-II D lesion

UR - http://www.scopus.com/inward/record.url?scp=85051109993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051109993&partnerID=8YFLogxK

U2 - 10.6515/ACS.201807_34(4).20180301A

DO - 10.6515/ACS.201807_34(4).20180301A

M3 - Article

AN - SCOPUS:85051109993

VL - 34

SP - 313

EP - 320

JO - Acta Cardiologica Sinica

JF - Acta Cardiologica Sinica

SN - 1011-6842

IS - 4

ER -